X
Edition:
United States

  • Business
    • Business Home
    • Legal
    • Deals
    • Aerospace & Defense
    • Finance
    • Autos
    • Reuters Summits
  • Markets
    • Markets Home
    • U.S. Markets
    • European Markets
    • Asian Markets
    • Global Market Data
    • Indices
    • Stocks
    • Bonds
    • Currencies
    • Comm & Energy
    • Futures
    • Funds
    • Earnings
    • Dividends
  • World
    • World Home
    • U.S.
    • Special Reports
    • Reuters Investigates
    • Euro Zone
    • Middle East
    • China
    • Japan
    • Mexico
    • Brazil
    • Africa
    • Russia
    • India
  • Politics
    • Politics Home
    • Election 2016
    • Polling Explorer
    • Just In
    • What Voters Want
    • Supreme Court
  • Tech
    • Technology Home
    • Science
    • Top 100 Global Innovators
    • Environment
    • Innovation
  • Commentary
    • Commentary Home
    • Podcasts
  • Breakingviews
    • Breakingviews Home
    • Breakingviews Video
  • Money
    • Money Home
    • Retirement
    • Lipper Awards
    • Analyst Research
    • Stock Screener
    • Fund Screener
  • Rio 2016
  • Pictures
    • Pictures Home
    • The Wider Image
    • Photographers
    • Focus 360
  • Video
World should ban human cloning, except medical: U.N.
  • Africa
    América Latina
  • عربي
    Argentina
  • Brasil
    Canada
  • 中国
    Deutschland
  • España
    France
  • India
    Italia
  • 日本
    México
  • РОССИЯ
    United Kingdom
  • United States
Science News | Sun Nov 11, 2007 12:46pm EST

World should ban human cloning, except medical: U.N.

An undated illustration of a strand of DNA. The world should quickly ban cloning of humans and only allow exceptions for strictly controlled research to help treat diseases such as diabetes or Alzheimer's, a U.N. study said on Sunday. REUTERS/National Institutes of Health/Handout
An undated illustration of a strand of DNA. The world should quickly ban cloning of humans and only allow exceptions for strictly controlled research to help treat diseases such as diabetes or Alzheimer's, a U.N. study said on Sunday. REUTERS/National Institutes of Health/Handout

OSLO The world should quickly ban cloning of humans and only allow exceptions for strictly controlled research to help treat diseases such as diabetes or Alzheimer's, a U.N. study said on Sunday.

Without a ban, experts at the U.N. University's Institute of Advanced Studies said that governments would have to prepare legal measures to protect clones from "potential abuse, prejudice and discrimination".

"A legally-binding global ban on work to create a human clone, coupled with freedom for nations to permit strictly controlled therapeutic research, has the greatest political viability of options available," the study said.

"Whichever path the international community chooses it will have to act soon -- either to prevent reproductive cloning or to defend the human rights of cloned individuals," said A.H. Zakri, head of the Institute, which is based in Yokohama, Japan.

Almost all governments oppose human cloning and more than 50 have legislation outlawing cloning. But negotiations about an international ban collapsed in 2005 because of disagreements over research cloning, also known as therapeutic cloning.

Research cloning can produce tissues that are a perfect genetic match of a person and so help grow cells to treat diseases such as strokes, spinal injuries, diabetes, Parkinson's or Alzheimer's, according to the study, which was made available in Oslo.

The United Nations in 2005 agreed a non-binding declaration to ban human cloning but left many ambiguities. "The declaration in itself is not an adequate response," said Brendan Tobin, an author of the study from the National University of Ireland.

"This has left us in a situation where maverick scientists can carry on with their research and that is likely to lead to an eventual cloning," he told Reuters.

The authors said laws should grant clones full human rights to protect from discrimination.

Otherwise, opponents of clones in an inheritance dispute, for instance, might say that a clone and the person from whom their cells were grown should only get a half share each.

"In the same way as an identical twin is an individual, a clone would be an individual," Tobin said.

The report noted that clones have been made of mice, sheep, pigs, cows and dogs and that U.S. researchers last year achieved the first cloning of a primate -- a rhesus monkey embryo cloned from adult cells and then grown to generate stem cells.

It said that national bans on cloning could be skirted since researchers could simply move elsewhere.

"Disgraced South Korean medical researcher Woo Sook Hwang, whose human clone claims were unsubstantiated, reportedly continues his work in Thailand," the U.N. study said.

(Editing by Giles Elgood)

Trending Stories

    Editor's Pick

    LIVE: Election 2016

    Sponsored Topics

    Next In Science News

    Piltdown breakdown: new details about a famed scientific hoax

    WASHINGTON Researchers applying modern forensic techniques to a century-old puzzle have laid bare intriguing new details about one of the most notorious scientific hoaxes on record, the so-called Piltdown Man, and are confident in the culprit's identity.

    What3words keeps Olympics visitors on track in Rio

    An innovative addressing system that assigns every patch of earth in the world an easy to remember three-word address is being used to help visitors get around at the Olympics in Rio de Jeneiro. Some 500,000 foreigners are expected to pass through the city during the Games that run until August 21.

    Paralysis partly reversed using brain-machine interface training

    Paraplegic patients recovered partial control and feeling in their limbs after training to use a variety of brain-machine interface technologies, according to new research published on Thursday in the journal "Scientific Reports."

    MORE FROM REUTERS

    From Around the Web By Taboola

    Sponsored Content By Dianomi

    X
    Follow Reuters:
    • Follow Us On Twitter
    • Follow Us On Facebook
    • Follow Us On RSS
    • Follow Us On Instagram
    • Follow Us On YouTube
    • Follow Us On LinkedIn
    Subscribe: Feeds | Newsletters | Podcasts | Apps
    Reuters News Agency | Brand Attribution Guidelines | Delivery Options

    Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Learn more about Thomson Reuters products:

    Eikon
    Information, analytics and exclusive news on financial markets - delivered in an intuitive desktop and mobile interface
    Elektron
    Everything you need to empower your workflow and enhance your enterprise data management
    World-Check
    Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks
    Westlaw
    Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology
    ONESOURCE
    The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs
    CHECKPOINT
    The industry leader for online information for tax, accounting and finance professionals

    All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

    • Site Feedback
    • Corrections
    • Advertise With Us
    • Advertising Guidelines
    • AdChoices
    • Terms of Use
    • Privacy Policy